 |
市場調查報告書
商品編碼
1547444
全球醫療保健合約研究外包市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測Global Healthcare Contract Research Outsourcing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
||||||
全球醫療保健合約研究外包市場需求預計將從 2023 年的 557.9 億美元達到近 1,062.5 億美元的市場規模，2024-2032 年研究期間複合年成長率為 7.42%。
醫療保健合約研究外包涉及聘請外部組織（稱為合約研究組織 (CRO)）代表生物技術公司、製藥公司和醫療器材製造商進行臨床試驗、研究和其他醫療保健相關研究。 CRO 提供專業知識、基礎設施和監管合規性，使醫療保健公司能夠更有效率、更具成本效益地將新療法和產品推向市場。將研究活動外包給 CRO 使公司能夠強調其核心競爭力，同時利用專業知識和資源來推進醫療創新。
市場動態
藥物開發和臨床試驗的複雜性和成本不斷增加，推動了醫療保健合約研究外包市場的發展。製藥和生技公司將各種研發活動外包給合約研究組織 (CRO)，以簡化流程、降低管理成本並獲得專業知識。醫療保健合約研究外包使公司能夠利用 CRO 的資源和能力來加速藥物發現、開發和法規核准流程。此外，隨著公司尋求接觸不同的患者群體和監管環境，臨床試驗的全球化和新興市場的擴張導致對外包服務的需求不斷成長。電子資料採集（EDC）系統和遠端監控解決方案等技術進步提高了 CRO 進行臨床試驗的效率和質量，進一步推動市場成長。此外，對個人化醫療和精準醫療保健的日益關注推動了對 CRO 提供的專業臨床研究服務的需求。監管壓力和遵守行業標準的需求也支持了外包趨勢，因為公司尋求降低風險並確保其產品獲得監管部門的批准。此外，COVID-19大流行推動了虛擬臨床試驗和遠端監控解決方案的採用，進一步增加了對醫療保健合約研究外包服務的需求。然而，臨床試驗的高昂成本和監管障礙可能會阻礙未來幾年的市場成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球醫療保健合約研究外包市場的各個細分市場進行了包容性評估。醫療保健合約研究外包產業的成長和趨勢為本研究提供了整體方法。
市場區隔
醫療保健合約研究外包市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。
按類型
- 藥物發現（標靶驗證、先導化合物辨識、先導化合物最佳化）
- 臨床前
- 臨床（一期試驗服務、二期試驗服務、三期試驗服務、四期試驗服務）
按服務分類
- 專案管理/臨床供應管理
- 資料管理
- 監管/醫療事務
- 醫學寫作
- 臨床監測
- 品質管理/保證
- 生物統計學
- 研究者付款
- 實驗室
- 患者和現場招募
- 科技
- 其他
區域分析
本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲醫療保健合約研究外包市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。醫療保健合約研究外包市場的主要參與者包括 ICON Plc、Charles River Laboratories、Syneos Health、IQVIA Inc.、GVK Biosciences Private Limited、Laboratory Corporation Of America Holdings、Parexel International Corporation、Medidata Solutions Inc.、Pharmaron GMBH。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
目錄
第1章：前言
- 報告說明
- 客觀的
- 目標受眾
- 獨特的銷售主張 (USP) 和產品
- 研究範圍
- 研究方法
- 市場研究過程
- 市場研究方法論
第 2 章：執行摘要
- 市場亮點
- 全球市場概況
第 3 章：醫療保健合約研究外包 - 產業分析
- 簡介 - 市場動態
- 市場促進因素
- 市場限制
- 機會
- 產業動態
- 波特五力分析
- 市場吸引力分析
- 按類型分類的市場吸引力分析
- 按服務分類的市場吸引力分析
- 市場吸引力分析：按地區
第 4 章：價值鏈分析
- 價值鏈分析
- 原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
- 潛在買家名單
- 行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢
第 5 章：全球醫療保健合約研究外包市場分析：按類型
- 按類型概述
- 按類型分析歷史和預測數據
- 藥物發現（標靶驗證、先導化合物辨識、先導化合物最佳化）
- 臨床前
- 臨床（一期試驗服務、二期試驗服務、三期試驗服務、四期試驗服務）
第 6 章：全球醫療保健合約研究外包市場分析：按服務分類
- 按服務概覽
- 按服務進行歷史和預測資料分析
- 專案管理/臨床供應管理
- 資料管理
- 監管/醫療事務
- 醫學寫作
- 臨床監測
- 品質管理/保證
- 生物統計學
- 研究者付款
- 實驗室
- 患者和現場招募
- 科技
- 其他
第 7 章：全球醫療保健合約研究外包市場分析：按地理位置
- 區域展望
- 介紹
- 北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
- 歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
- 亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
- 拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
- 中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析
第 8 章：醫療保健合約研究外包公司的競爭格局
- 醫療保健合約研究外包市場競爭
- 夥伴關係/協作/協議
- 併購
- 新產品發布
- 其他發展
第 9 章：公司簡介
- 頂級公司市佔率分析
- 市場集中度
- ICON Plc
- 公司概況
- 公司收入
- 產品
- 最新動態
- Charles River Laboratories
- 公司概況
- 公司收入
- 產品
- 最新動態
- Syneos Health
- 公司概況
- 公司收入
- 產品
- 最新動態
- IQVIA Inc.
- 公司概況
- 公司收入
- 產品
- 最新動態
- GVK Biosciences Private Limited
- 公司概況
- 公司收入
- 產品
- 最新動態
- Laboratory Corporation Of America Holdings
- 公司概況
- 公司收入
- 產品
- 最新動態
- Parexel International Corporation
- 公司概況
- 公司收入
- 產品
- 最新動態
- Medidata Solutions Inc.
- 公司概況
- 公司收入
- 產品
- 最新動態
- Pharmaron GMBH
- 公司概況
- 公司收入
- 產品
- 最新動態
註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內
The global demand for Healthcare Contract Research Outsourcing Market is presumed to reach the market size of nearly USD 106.25 Billion by 2032 from USD 55.79 Billion in 2023 with a CAGR of 7.42% under the study period 2024-2032.
Healthcare contract research outsourcing involves hiring external organizations, known as contract research organizations (CROs), to conduct clinical trials, research studies, and other healthcare-related research on behalf of biotechnology firms, pharmaceutical companies, and medical device manufacturers. CROs provide expertise, infrastructure, and regulatory compliance, allowing healthcare companies to bring new treatments and products to market more efficiently and cost-effectively. Outsourcing research activities to CROs enables companies to emphasize their core competencies while leveraging specialized knowledge and resources to advance medical innovation.
MARKET DYNAMICS
The increasing complexity and cost of drug development and clinical trials drive the healthcare contract research outsourcing market. Pharmaceutical and biotechnology companies outsource various research and development activities to contract research organizations (CROs) to streamline processes, reduce overhead costs, and access specialized expertise. Healthcare contract research outsourcing enables companies to leverage the resources and capabilities of CROs to accelerate drug discovery, development, and regulatory approval processes. Additionally, the globalization of clinical trials and the expansion of emerging markets contribute to the growing demand for outsourcing services as companies seek to access diverse patient populations and regulatory environments. Technological progress, such as electronic data capture (EDC) systems and remote monitoring solutions, enhance the efficiency and quality of clinical trials carried out by CROs, further driving market growth. Furthermore, the growing focus on personalized medicine & precision healthcare drives the demand for specialized clinical research services offered by CROs. Regulatory pressures and the need for compliance with industry standards also support the outsourcing trend, as companies seek to mitigate risks and ensure regulatory approval for their products. Moreover, the COVID-19 pandemic has propelled the adoption of virtual clinical trials and remote monitoring solutions, further boosting the demand for healthcare contract research outsourcing services. However, the high cost of clinical trials and regulatory hurdles may hinder market growth in the next few years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Healthcare Contract Research Outsourcing. The growth and trends of Healthcare Contract Research Outsourcing industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Healthcare Contract Research Outsourcing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Drug Discovery (Target Validation, Lead Identification, Lead Optimization)
- Pre-clinical
- Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services)
By Services
- Project Management/Clinical Supply Management
- Data Management
- Regulatory/Medical Affairs
- Medical Writing
- Clinical Monitoring
- Quality Management/ Assurance
- Bio-statistics
- Investigator Payments
- Laboratory
- Patient And Site Recruitment
- Technology
- Others
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Healthcare Contract Research Outsourcing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Healthcare Contract Research Outsourcing market include ICON Plc, Charles River Laboratories, Syneos Health, IQVIA Inc., GVK Biosciences Private Limited, Laboratory Corporation Of America Holdings, Parexel International Corporation, Medidata Solutions Inc., Pharmaron GMBH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. HEALTHCARE CONTRACT RESEARCH OUTSOURCING - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Services
- 3.7.3 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY TYPE
- 5.1. Overview By Type
- 5.2. Historical and Forecast Data Analysis By Type
- 5.3. Drug Discovery (Target Validation, Lead Identification, Lead Optimization) Historic and Forecast Sales By Regions
- 5.4. Pre-clinical Historic and Forecast Sales By Regions
- 5.5. Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services) Historic and Forecast Sales By Regions
6. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY SERVICES
- 6.1. Overview By Services
- 6.2. Historical and Forecast Data Analysis By Services
- 6.3. Project Management/Clinical Supply Management Historic and Forecast Sales By Regions
- 6.4. Data Management Historic and Forecast Sales By Regions
- 6.5. Regulatory/Medical Affairs Historic and Forecast Sales By Regions
- 6.6. Medical Writing Historic and Forecast Sales By Regions
- 6.7. Clinical Monitoring Historic and Forecast Sales By Regions
- 6.8. Quality Management/ Assurance Historic and Forecast Sales By Regions
- 6.9. Bio-statistics Historic and Forecast Sales By Regions
- 6.10. Investigator Payments Historic and Forecast Sales By Regions
- 6.11. Laboratory Historic and Forecast Sales By Regions
- 6.12. Patient And Site Recruitment Historic and Forecast Sales By Regions
- 6.13. Technology Historic and Forecast Sales By Regions
- 6.14. Others Historic and Forecast Sales By Regions
7. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY
- 7.1. Regional Outlook
- 7.2. Introduction
- 7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
- 7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
- 7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
- 7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
- 7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis
8. COMPETITIVE LANDSCAPE OF THE HEALTHCARE CONTRACT RESEARCH OUTSOURCING COMPANIES
- 8.1. Healthcare Contract Research Outsourcing Market Competition
- 8.2. Partnership/Collaboration/Agreement
- 8.3. Merger And Acquisitions
- 8.4. New Product Launch
- 8.5. Other Developments
9. COMPANY PROFILES OF HEALTHCARE CONTRACT RESEARCH OUTSOURCING INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Market Concentration Rate
- 9.3. ICON Plc
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
- 9.4. Charles River Laboratories
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
- 9.5. Syneos Health
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
- 9.6. IQVIA Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
- 9.7. GVK Biosciences Private Limited
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
- 9.8. Laboratory Corporation Of America Holdings
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
- 9.9. Parexel International Corporation
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
- 9.10. Medidata Solutions Inc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
- 9.11. Pharmaron GMBH
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Type (USD MN)
- Drug Discovery (Target Validation, Lead Identification, Lead Optimization) Market Sales By Geography (USD MN)
- Pre-clinical Market Sales By Geography (USD MN)
- Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services) Market Sales By Geography (USD MN)
- Analysis By Services (USD MN)
- Project Management/Clinical Supply Management Market Sales By Geography (USD MN)
- Data Management Market Sales By Geography (USD MN)
- Regulatory/Medical Affairs Market Sales By Geography (USD MN)
- Medical Writing Market Sales By Geography (USD MN)
- Clinical Monitoring Market Sales By Geography (USD MN)
- Quality Management/ Assurance Market Sales By Geography (USD MN)
- Bio-statistics Market Sales By Geography (USD MN)
- Investigator Payments Market Sales By Geography (USD MN)
- Laboratory Market Sales By Geography (USD MN)
- Patient And Site Recruitment Market Sales By Geography (USD MN)
- Technology Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Healthcare Contract Research Outsourcing Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Healthcare Contract Research Outsourcing Report
- Market Research Process
- Market Research Methodology
- Global Healthcare Contract Research Outsourcing Market Size, By Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Type
- Market Attractiveness Analysis By Services
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Type (USD MN)
- Drug Discovery (Target Validation, Lead Identification, Lead Optimization) Market Sales By Geography (USD MN)
- Pre-clinical Market Sales By Geography (USD MN)
- Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services) Market Sales By Geography (USD MN)
- Global Market Analysis By Services (USD MN)
- Project Management/Clinical Supply Management Market Sales By Geography (USD MN)
- Data Management Market Sales By Geography (USD MN)
- Regulatory/Medical Affairs Market Sales By Geography (USD MN)
- Medical Writing Market Sales By Geography (USD MN)
- Clinical Monitoring Market Sales By Geography (USD MN)
- Quality Management/ Assurance Market Sales By Geography (USD MN)
- Bio-statistics Market Sales By Geography (USD MN)
- Investigator Payments Market Sales By Geography (USD MN)
- Laboratory Market Sales By Geography (USD MN)
- Patient And Site Recruitment Market Sales By Geography (USD MN)
- Technology Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
